Pyridazinodiazepines as a high-affinity, P-2-P-3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor

被引：48

作者：

Dolle, RE ^{[1
]}

Prasad, CVC ^{[1
]}

Prouty, CP ^{[1
]}

Salvino, JM ^{[1
]}

Awad, MMA ^{[1
]}

Schmidt, SJ ^{[1
]}

Hoyer, D ^{[1
]}

Ross, TM ^{[1
]}

Graybill, TL ^{[1
]}

Speier, GJ ^{[1
]}

Uhl, J ^{[1
]}

Miller, BE ^{[1
]}

Helaszek, CT ^{[1
]}

Ator, MA ^{[1
]}

机构：

[1] SANOFI WINTHROP INC,COLLEGEVILLE,PA 19426

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1997年 / 40卷 / 13期

关键词：

D O I：

10.1021/jm9701637

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1941 / 1946

页数：6

共 28 条

[1]

ATOR MA, 1995, CURR PHARM DESIGN, V1, P191

[2] THE DESIGN AND SYNTHESIS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR CILAZAPRIL AND RELATED BICYCLIC COMPOUNDS [J].

ATTWOOD, MR ;

HASSALL, CH ;

KROHN, A ;

LAWTON, G ;

REDSHAW, S .

JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1986, (06) :1011-1019

[3]

ATTWOOD MR, Patent No. 35850

[4]

BERNSTEIN PR, 1993, Patent No. 9321214

[5]

BERNSTEIN PR, 1993, Patent No. 9321210

[6] ACTIVATION OF INTERLEUKIN-1-BETA BY A CO-INDUCED PROTEASE [J].

BLACK, RA ;

KRONHEIM, SR ;

SLEATH, PR .

FEBS LETTERS, 1989, 247 (02) :386-390

[7] DESIGN OF ORALLY-ACTIVE, NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE [J].

BROWN, FJ ;

ANDISIK, DW ;

BERNSTEIN, PR ;

BRYANT, CB ;

CECCARELLI, C ;

DAMEWOOD, JR ;

WOOLSON, SA ;

EDWARDS, PD ;

EARLEY, RA ;

FEENEY, S ;

GREEN, RC ;

GOMES, B ;

KOSMIDER, BJ ;

KRELL, RD ;

SHAW, A ;

STEELMAN, GB ;

THOMAS, RN ;

VACEK, EP ;

VEALE, CA ;

TUTHILL, PA ;

WARNER, P ;

WILLIAMS, JC ;

WOLANIN, DJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) :1259-1261

[8] ASPARTYL ALPHA-((1-PHENYL-3-(TRIFLUOROMETHYL)PYRAZOL-5-YL)OXY)METHYL KETONES AS INTERLEUKIN-1-BETA CONVERTING-ENZYME INHIBITORS - SIGNIFICANCE OF THE P-1 AND P-3 AMIDO NITROGENS FOR ENZYME-PEPTIDE INHIBITOR BINDING [J].

DOLLE, RE ;

SINGH, J ;

RINKER, J ;

HOYER, D ;

PRASAD, CVC ;

GRAYBILL, TL ;

SALVINO, JM ;

HELASZEK, CT ;

MILLER, RE ;

ATOR, MA .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) :3863-3866

[9] ASPARTYL ALPHA-((DIPHENYLPHOSPHINYL)OXY)METHYL KETONES AS NOVEL INHIBITORS OF INTERLEUKIN-1-BETA CONVERTING-ENZYME - UTILITY OF THE DIPHENYLPHOSPHINIC ACID LEAVING GROUP FOR THE INHIBITION OF CYSTEINE PROTEASES [J].

DOLLE, RE ;

SINGH, J ;

WHIPPLE, D ;

OSIFO, IK ;

SPEIER, G ;

GRAYBILL, TL ;

GREGORY, JS ;

HARRIS, AL ;

HELASZEK, CT ;

MILLER, RE ;

ATOR, MA .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :220-222

[10] First examples of peptidomimetic inhibitors of interleukin-1 beta converting enzyme [J].

Dolle, RE ;

Prouty, CP ;

Prasad, CVC ;

Cook, E ;

Saha, A ;

Ross, TM ;

Salvino, JM ;

Helaszek, CT ;

Ator, MA .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (13) :2438-2440

← 1 2 3 →